News | ASTRO | December 06, 2019

ASTRO Congratulates Stephen Hahn, M.D., for Securing Senate Committee Approval to lead FDA

Hahn has served on the ASTRO Board of Directors and has broad knowledge as a clinician, researcher, educator and administrative leader

Stephen Hahn, M.D., FASTRO

Stephen Hahn, M.D., FASTRO

December 6, 2019 — The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, M,D,, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA). Next, Senate Majority Leader Mitch McConnell (R-Ky.) will need to schedule a full Senate vote to confirm Hahn.

"On behalf of our more than 10,000 members, ASTRO commends Dr. Hahn for his thoughtful answers outlining his commitment to consumer safety during the committee hearing. We are pleased that Dr. Hahn received the votes needed to secure committee approval and will move on to a final confirmation vote. We join the growing number of research, provider and patient groups who also support Dr. Hahn, and we urge the Senate to swiftly confirm his nomination as head of the FDA," said Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors.

Hahn, the chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, was nominated Nov. 1 by President Trump to be the nation’s 24th FDA Commissioner. On behalf of ASTRO, DeWeese and other radiation oncology leaders expressed their support of Dr. Hahn's nomination when it was announced by the White House. The Cancer Leadership Council, a coalition of approximately 30 professional societies, cancer patient organizations and research organizations including ASTRO, also voiced its support of Hahn earlier this week.

Related content:

ASTRO supports nomination of Stephen Hahn, M.D., FASTRO, to lead U.S. FDA

Related Content

Improvised PPE face mask worn by a radiology technologist during rounds atSen. Gerardo M. Roxas Memorial District Hospital in Iloilo City, Philippines. #COVID19 #Coronavirus #SARScov2

Improvised PPE face mask worn by a radiology technologist during rounds atSen. Gerardo M. Roxas Memorial District Hospital in Iloilo City, Philippines

Feature | Coronavirus (COVID-19) | April 02, 2020 | Dave Fornell, Editor
There has been an extraordinary demand on personal protective equipment (PPE) with the rapid spread of the novel...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — In a...
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
RSNA's open data repository will compile images and correlative data to create a comprehensive source for COVID-19 research and education efforts #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 30, 2020
March 30, 2020 — The medical imaging community around the world is uniting to help address the...
Phase III response to the COVID-19 public health emergency (PHE) CARES Act signed into law #CARESAct #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
Feature | Coronavirus (COVID-19) | March 28, 2020 | By Melinda Taschetta-Millane
On March 27, the House of Representatives approved a historic $2
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.

News | PET-CT | March 26, 2020
March 26, 2020 — Novel, fully digital, high-resolution...